Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Stem Cell Research

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 30 articles:
HTML format



Single Articles


    November 2021
  1. CIERPIKOWSKI P, Lis-Nawara A, Bar J
    SHH Expression Is Significantly Associated With Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:5405-5413.
    PubMed     Abstract available


  2. TSOCHANTARIDIS I, Voulgaridou GP, Giatromanolaki A, Koukourakis MI, et al
    Profiling of Aldehyde Dehydrogenase Isoforms in In Vitro Formed Tumorspheres.
    Anticancer Res. 2021;41:5481-5488.
    PubMed     Abstract available


    October 2021
  3. MIYAMOTO S, Fukui T, Horitani S, Tanimura Y, et al
    Linker Threonine-phosphorylated Smad2/3 Is a Biomarker of Colorectal Neoplastic Stem-like Cells that Correlates With Carcinogenesis.
    Anticancer Res. 2021;41:4789-4799.
    PubMed     Abstract available


    August 2021
  4. AGAWA K, Yamashita K, Nakagawa A, Yamada K, et al
    Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2021;41:4117-4126.
    PubMed     Abstract available


    July 2021
  5. HYUN CL, Park SJ, Kim HS, Song HJ, et al
    The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer.
    Anticancer Res. 2021;41:3689-3698.
    PubMed     Abstract available


  6. LIM JH, Go G, Lee SH
    PrPC Regulates the Cancer Stem Cell Properties via Interaction With c-Met in Colorectal Cancer Cells.
    Anticancer Res. 2021;41:3459-3470.
    PubMed     Abstract available


  7. KIM CY, Kim YC, Oh JH, Kim MH, et al
    HOXB5 Confers Tamoxifen Resistance in Breast Cancer Cells and Promotes Tumor Aggression and Progression.
    Anticancer Res. 2021;41:3409-3417.
    PubMed     Abstract available


  8. RUZANOVA VS, Proskurina AS, Ritter GS, Efremov YR, et al
    Experimental Comparison of the In Vivo Efficacy of Two Novel Anticancer Therapies.
    Anticancer Res. 2021;41:3371-3387.
    PubMed     Abstract available


  9. TROSCHEL FM, Linsenmaier M, Borrmann K, Eich HT, et al
    Heparanase Expression Is Associated With Cancer Stem Cell Features and Radioresistance in Hodgkin's Lymphoma Cells.
    Anticancer Res. 2021;41:3299-3308.
    PubMed     Abstract available


    June 2021
  10. SHIN J, Baik SK, Yoon Y, Hwang S, et al
    DNA-binding Cell-penetrating Peptide-based TRAIL Over-expression in Adipose Tissue-derived Mesenchymal Stem Cells Inhibits Glioma U251MG Growth.
    Anticancer Res. 2021;41:2859-2866.
    PubMed     Abstract available


    March 2021
  11. MO S, Ku HJ, Choi SH, Jeong HJ, et al
    470 nm LED Irradiation Inhibits the Invasiveness of CD133-positive Human Colorectal Cancer Stem Cells by Suppressing the Cyclooxygenase-2/prostaglandin E2 Pathway.
    Anticancer Res. 2021;41:1407-1420.
    PubMed     Abstract available


  12. PARK SY, Seo YR, Ko MJ, Lee JH, et al
    Targeting CALM2 Inhibits Hepatocellular Carcinoma Growth and Metastasis by Suppressing E2F5-mediated Cell Cycle Progression.
    Anticancer Res. 2021;41:1315-1325.
    PubMed     Abstract available


  13. TURNOVCOVA K, Marekova D, Sursal T, Krupova M, et al
    Understanding the Biological Basis of Glioblastoma Patient-derived Spheroids.
    Anticancer Res. 2021;41:1183-1195.
    PubMed     Abstract available


    February 2021
  14. YAMASHITA N, Oyama T, So T, Miyata T, et al
    Association Between CD133 Expression and Prognosis in Human Lung Adenocarcinoma.
    Anticancer Res. 2021;41:905-910.
    PubMed     Abstract available


  15. PAPADAKI MA, Aggouraki D, Vetsika EK, Xenidis N, et al
    Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients.
    Anticancer Res. 2021;41:661-670.
    PubMed     Abstract available


    January 2021
  16. THADI A, Morano WF, Khalili M, Babcock BD, et al
    Molecular Targeting of H/MDM-2 Oncoprotein in Human Colon Cancer Cells and Stem-like Colonic Epithelial-derived Progenitor Cells.
    Anticancer Res. 2021;41:27-42.
    PubMed     Abstract available


    December 2020
  17. PALEK R, Rosendorf J, Maleckova A, Vistejnova L, et al
    Influence of Mesenchymal Stem Cell Administration on The Outcome of Partial Liver Resection in a Porcine Model of Sinusoidal Obstruction Syndrome.
    Anticancer Res. 2020;40:6817-6833.
    PubMed     Abstract available


  18. MALAER JD, Mathew PA
    Role of LLT1 and PCNA as Natural Killer Cell Immune Evasion Strategies of HCT 116 Cells.
    Anticancer Res. 2020;40:6613-6621.
    PubMed     Abstract available


    November 2020
  19. CZYZEWSKI K, DEbski R, Bartoszewicz N, Demidowicz E, et al
    Impact of Palifermin on Transplant Outcomes in Children and Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Anticancer Res. 2020;40:6531-6537.
    PubMed     Abstract available


  20. NAGASHIMA T, Oshima T, Hiroshima Y, Yokose T, et al
    Clinical Significance of Tumour CD44v and MIST1 Expression in Patients With Non-small-cell Lung Cancer.
    Anticancer Res. 2020;40:6407-6416.
    PubMed     Abstract available


  21. PAN Y, Chiu YH, Chiu SC, Cho DY, et al
    Inhibition of Bruton's Tyrosine Kinase Suppresses Cancer Stemness and Promotes Carboplatin-induced Cytotoxicity Against Bladder Cancer Cells.
    Anticancer Res. 2020;40:6093-6099.
    PubMed     Abstract available


    October 2020
  22. STUDER U, Khanna N, Leuzinger K, Hirsch HH, et al
    Incidence of CMV Replication and the Role of Letermovir Primary/Secondary Prophylaxis in the Early Phase After Allogeneic Hematopoietic Stem Cell Transplantation - A Single Centre Study.
    Anticancer Res. 2020;40:5909-5917.
    PubMed     Abstract available


  23. LI J, Seligson N, Zhang X, Johnson J, et al
    Association of ANRIL Polymorphism With Overall Survival in Adult Patients With Hematologic Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation.
    Anticancer Res. 2020;40:5707-5713.
    PubMed     Abstract available


  24. YENILMEZ EN, Genc D, Farooqi AA, Tunoglu S, et al
    Mesenchymal Stem Cells Combined With IFNgamma Induce Apoptosis of Breast Cancer Cells Partially Through TRAIL.
    Anticancer Res. 2020;40:5641-5647.
    PubMed     Abstract available


  25. GO G, Yun CW, Yoon YM, Lim JH, et al
    Role of PrP(C) in Cancer Stem Cell Characteristics and Drug Resistance in Colon Cancer Cells.
    Anticancer Res. 2020;40:5611-5620.
    PubMed     Abstract available


  26. MIYASHITA M, Tomogane M, Nakamura Y, Shimizu T, et al
    Sphere-derived Prostate Cancer Stem Cells Are Resistant to gammadelta T Cell Cytotoxicity.
    Anticancer Res. 2020;40:5481-5487.
    PubMed     Abstract available


  27. YUNO T, Miyata Y, Matsuo T, Mukae Y, et al
    Relationship Between Stage-specific Embryonic Antigen-4 and Anti-cancer Effects of Neoadjuvant Hormonal Therapy in Prostate Cancer.
    Anticancer Res. 2020;40:5567-5575.
    PubMed     Abstract available


  28. MARGAN MM, Cimpean AM, Ceausu AR, Raica M, et al
    Differential Expression of E-Cadherin and P-Cadherin in Breast Cancer Molecular Subtypes.
    Anticancer Res. 2020;40:5557-5566.
    PubMed     Abstract available


  29. JEONG JY, Jeong W, Kim HJ
    Promotion of Chondrosarcoma Cell Survival, Migration and Lymphangiogenesis by Periostin.
    Anticancer Res. 2020;40:5463-5469.
    PubMed     Abstract available


    September 2020
  30. KIM DH, Kang DY, Sp N, Jo ES, et al
    Methylsulfonylmethane Induces Cell Cycle Arrest and Apoptosis, and Suppresses the Stemness Potential of HT-29 Cells.
    Anticancer Res. 2020;40:5191-5200.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: